Cargando…

Metabolic adverse events of multitarget kinase inhibitors: a systematic review

PURPOSE: Multitargeted kinase inhibitors (MKIs) are used for the treatment of several cancers. By targeting multiple signaling pathways, MKIs have become cornerstones of the oncologic treatment. Although their use leads to important results in terms of survival, treatment with MKIs can determine imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Acitelli, Elisa, Maiorca, Carlo, Grani, Giorgio, Maranghi, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239378/
https://www.ncbi.nlm.nih.gov/pubmed/37067769
http://dx.doi.org/10.1007/s12020-023-03362-2